Plurify

Plurify is a biotechnology company developing PluRNA, a programmable RNA platform for sustained protein expression without genome integration.

Its technology is designed to engineer cells through controllable RNA-based programmes, with applications in stem-cell therapy manufacturing, cell purification, biologics production and research models.

The company collaborates with the Cell and Gene Therapy Catapult and reports industrial use with Novo Nordisk. PluRNA remains a developing platform rather than an approved therapeutic product.